The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Bizily Scott

Reporting owner CIK 0001920738 · Chief Legal Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Bizily ScottBizily ScottBizily Scott · October 16, 2026 · Exercise / conversion · Common StockBizily Scott · December 16, 2025 · Exercise / conversion · Common StockBizily Scott · November 17, 2025 · Exercise / conversion · Common StockBizily Scott · October 24, 2025 · Exercise / conversion · Common StockBizily Scott · October 16, 2025 · Exercise / conversion · Common StockOct 16, 2025Oct 16, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 16, 20264D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Dec 16, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Nov 17, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Oct 24, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Oct 16, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listings
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listings
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listings
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listings
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,0846.49Value: 7,035.16Currency not specifiedView ↗
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listings
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗